<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Inst Med Trop Sao Paulo</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev. Inst. Med. Trop. Sao Paulo</journal-id>
      <journal-id journal-id-type="publisher-id">rimtsp</journal-id>
      <journal-title-group>
        <journal-title>Revista do Instituto de Medicina Tropical de S&#xE3;o Paulo</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-4665</issn>
      <issn pub-type="epub">1678-9946</issn>
      <publisher>
        <publisher-name>Instituto de Medicina Tropical</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27049704</article-id>
      <article-id pub-id-type="pmc">4727136</article-id>
      <article-id pub-id-type="doi">10.1590/S0036-46652015000600007</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Virology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>MENINGOENCEPHALITIS DUE TO VARICELLA ZOSTER VIRUS IN AIDS PATIENTS.
REPORT OF ELEVEN CASES AND REVIEW OF THE LITERATURE</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Meningoencefalite pelo v&#xED;rus varicela-zoster em pacientes com AIDS.
Relato de onze casos e revis&#xE3;o da literatura</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>CORTI</surname>
            <given-names>Marcelo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>VILLAFA&#xD1;E</surname>
            <given-names>Mar&#xED;a F.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>VITTAR</surname>
            <given-names>Natalia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>BANCO</surname>
            <given-names>Mar&#xED;a C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>PRIARONE</surname>
            <given-names>Maia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MAMMANA</surname>
            <given-names>Lilia</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>GILARDI</surname>
            <given-names>Leonardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Hospital General de Infecciosas F. J. Mu&#xF1;iz, HIV/AIDS Division, Buenos
Aires, Argentina</aff>
      <aff id="aff2"><label>2</label>Universidad de Buenos Aires, Facultad de Medicina, Buenos Aires,
Argentina</aff>
      <aff id="aff3"><label>3</label>Hospital General de Infecciosas F. J. Mu&#xF1;iz, Virology Laboratory, Buenos
Aires, Argentina</aff>
      <aff id="aff4"><label>4</label>Sociedad Iberoamericana de Informaci&#xF3;n Cient&#xED;fica, Scientific
Coordinator, Buenos Aires, Argentina</aff>
      <author-notes>
        <corresp id="c01"><bold>Correspondence to</bold>: Dr. Marcelo Corti, Infectious Diseases F. J. Mu&#xF1;iz
Hospital, HIV/AIDS Department, Pu&#xE1;n 381 2&#xBA; C 1406 CQG, Buenos Aires, Argentina.
Phone: +54 11 4432.3762. E-mail: <email>marcelocorti@fibertel.com.ar</email></corresp>
        <fn fn-type="conflict" id="fn01">
          <p>Conflict of interest: None.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <volume>57</volume>
      <issue>6</issue>
      <fpage>505</fpage>
      <lpage>508</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>02</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Neurological complications of varicella-zoster virus (VZV) are infrequent and include
various clinical pictures. The reactivation of VZV in patients with AIDS is generally
associated with an acute and severe meningoencephalitis. We report the
epidemiological, clinical and virological data from 11 consecutive patients with
diagnosis of HIV/AIDS and central nervous system (CNS) involvement due to VZV. All
patients were male and seropositive for HIV. The primary risk factor for HIV
infection was unprotected sexual contact. The median of CD4 T cell count was 142
cells/&#xB5;L. All of them presented signs and symptoms of meningoencephalitis. Six
patients (54.5%) presented pleocytosis; they all showed high CSF protein
concentrations with a median of 2.1 g/dL. Polymerase chain reaction of cerebrospinal
fluid specimen was positive for VZV in all of them and they were treated with
intravenous acyclovir at doses of 30/mg/kg/day for 21 days. Overall survival was 63%
(7 of 11 patients). The four dead patients had low cellular counts in CSF, below the
median of this parameter. VZV should be included among the opportunistic pathogens
that can involve CNS with a diffuse and severe meningoencephalitis in patients with
advanced HIV/AIDS disease.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>As complica&#xE7;&#xF5;es neurol&#xF3;gicas do v&#xED;rus varicela-zoster (VVZ) s&#xE3;o pouco frequentes e
incluem v&#xE1;rios quadros cl&#xED;nicos. A reativa&#xE7;&#xE3;o do VVZ em pacientes com AIDS &#xE9;
geralmente associada com meningoencefalite aguda e grave. N&#xF3;s relatamos os dados
epidemiol&#xF3;gicos, cl&#xED;nicos e virol&#xF3;gicos de onze pacientes consecutivos com
diagn&#xF3;stico de HIV/AIDS e comprometimento do sistema nervoso central (SNC) devido ao
VVZ. Todos os pacientes eram do sexo masculino e soropositivos para HIV. O principal
fator de risco para a infec&#xE7;&#xE3;o pelo HIV foi o contato sexual sem prote&#xE7;&#xE3;o. A mediana
da contagem de c&#xE9;lulas CD4 T foi de 142 cel/&#xB5;L. Todos apresentavam sinais e sintomas
devido &#xE0; meningoencefalite. Seis pacientes (54,5%) apresentaram pleiocitose; todos
apresentaram hiperproteinorraquia com mediana de 2,1 g/dL. A rea&#xE7;&#xE3;o em cadeia da
polimerase de amostra do l&#xED;quido cefalorraquidiano foi positiva para VVZ em todos
eles. Todos os pacientes foram tratados com aciclovir por via intravenosa em doses de
30 mg/kg/dia durante 21 dias. A sobrevida global foi de 63% (sete de 11 pacientes).
Os quatro pacientes mortos tiveram uma escassa resposta celular no LCR abaixo da
mediana para este par&#xE2;metro. O VVZ deve ser inclu&#xED;do entre os pat&#xF3;genos oportunistas
que podem comprometer o SNC com meningoencefalite difusa e grave em pacientes com
doen&#xE7;a avan&#xE7;ada por HIV/SIDA.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>AIDS</kwd>
        <kwd>HIV</kwd>
        <kwd>Meningoencephalitis</kwd>
        <kwd>Varicella-zoster virus</kwd>
        <kwd>Polymerase chain reaction</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="13"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Varicella-zoster virus (VZV) is a member of herpesvirus family that causes chickenpox
(varicella), generally in infants, and may reactivate decades later to produce shingles
(zoster). Neurological complications of VZV are rarely seen during the primary infection
(varicella cerebellitis) and more often during the reactivation phase<xref rid="B09" ref-type="bibr">9</xref>. </p>
      <p>The most severe neurological complications occur in immunocompromised patients and
include aseptic meningitis, encephalitis with vasculitis, ventriculitis, severe
necrotizing myelitis, post-herpetic neuralgia, and leucoencephalopathy<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B13" ref-type="bibr">13</xref>.</p>
      <p>We present a series of 11 AIDS patients who developed acute meningoencephalitis due to
VZV. </p>
    </sec>
    <sec sec-type="materials|methods">
      <title>MATERIAL AND METHODS</title>
      <p>The epidemiological, clinical, microbiological and virological characteristics of 11
patients infected with human immunodeficiency virus (HIV), with central nervous system
(CNS) involvement caused by VZV, were retrospectively analyzed from January 2002 to
November 2014. We included patients hospitalized in the HIV/AIDS Department of the
Infectious Diseases F.J. <italic>Mu&#xF1;iz</italic> Hospital with polymerase chain reaction
(PCR) positive for VZV in cerebrospinal fluid (CSF) in our Hospital's virology
laboratory records. Clinical and neurological examinations were performed for all of the
patients. Upon physical examination, all patients included in this study had
neurological signs and/or symptoms compatible with the diagnosis of diffuse
meningoencephalitis. In all of them, a lumbar puncture was performed.</p>
      <p>White cell count was studied in all CSF samples, along with protein levels, glucose
levels, common bacteria, mycobacteria, fungi, and parasites with Gram, Zielh Neelsen,
Indian ink stain, and direct microscopic examination, respectively, followed by the
corresponding culture methods. Further to this, neuroherpeviruses and JC virus were
investigated by PCR. Blood cultures for common bacteria, fungi, and mycobacteria, and
CD4+ T cell counts were also performed in all patients.</p>
      <p>In order to define a case, we included only those patients with neurological
manifestations of meningoencephalitis, positive VZV-PCR in CSF, even in the absence of
clinical symptoms, and exclusion of other causes of CNS involvement in these
patients.</p>
      <p>Definitive diagnosis of VZV meningoencephalitis was made by DNA qualitative detection by
PCR in CSF specimens. Aliquots of CSF samples were stored at -70 &#xB0;C until analysis.
Until 2010, samples had been studied by the commercial Herpes Virus Multiplex kit
(HVM-HERPLEX, Genomica, Spain) following the manufacturer's instructions. This is a
multiplex PCR that amplifies and detects the genome of Herpes simplex-1 (HSV-1) and 2
(HSV-2) and Herpes varicella-zoster (HVZ) in a single tube as well as the
cytomegalovirus (CMV) genome, Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6).
Every tube has an internal amplification control and the amplified products are detected
by hybridization with specific probes in a microplate. The analytical sensitivity
reported by the manufacturer is 2 genome equivalents for HSV-1, HSV-2, EBV, and between
2 and 20 genome equivalents for VZV, HHV-6 and CMV. From 2011 to 2014, the detection of
DNA for all of these viruses was performed by TaqMan real time PCR (RT-PCR), using a
commercially available individualized kit for each virus. The VZV Q-PCR Alert kit
(Elitechgroup, Italy) was used for qualitative VZV-PCR following the manufacturer's
instructions. The target amplification region of this reaction is the Major DNA binding
protein from VZV (ORF 29), the internal control is the human beta globin gene and the
analytical sensitivity reported is 10 DNA copies/reaction.</p>
    </sec>
    <sec sec-type="results">
      <title>RESULTS</title>
      <p>All of the patients were male and seropositive for HIV. The median age at the time ofVZV
meningoencephalitis diagnosis was 37 years (mean of age 35.27 &#xB1; 9.22 years). Primary
risk factor for HIV infection was unprotected sexual contact in all patients. Median CD4
T cell count at the time of VZV meningoencephalitis was 142 cells/&#xB5;L, and a
heterogeneous mean &#xB1; SD 132 &#xB1; 83 cells/&#xB5;L (interquartile range [IQR]: 147.5 cells/&#xB5;L).
All patients were diagnosed with AIDS based on the clinical history of AIDS defining
illnesses or the CD4 T cell count below 200 cells/&#xB5;L. At the time of VZV
meningoencephalitis there was no evidence of other neurological opportunistic infections
or AIDS-defining illnesses. Due to their own decision, none of the patients had received
antiretroviral therapy. Main results are summarized in <xref ref-type="table" rid="t01">Table 1</xref>.</p>
      <p>
<table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><title>
<bold>-</bold> Main basal characteristics of the study group.</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>#</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Age (years)</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>T-HIV-D (years)</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>CD4 (/&#xB5;L)</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Prior ND</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Prior non ND</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">Syphilis</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">233</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">Gut tuberculosis</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">83</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">Hepatitis B</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">223</td><td align="left" rowspan="1" colspan="1">Toxoplasmosis</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">Pulmonary tuberculosis (*)</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">142</td><td align="left" rowspan="1" colspan="1">Toxoplasmosis</td><td align="left" rowspan="1" colspan="1">Disseminated histoplasmosis
(*)</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">189</td><td align="left" rowspan="1" colspan="1">Ophthalmic zoster</td><td align="left" rowspan="1" colspan="1">Non Hodgkin lymphoma</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><p>T-HIV-D: time from HIV diagnosis to VZV meningoencephalitis diagnosis. N/A:
not available. ND: neurological diseases. (*) among others.</p></fn></table-wrap-foot></table-wrap>
</p>
      <p>Clinical examination revealed headache in eight patients (72%); fever in seven patients
(63%); meningism in four patients (36%); focal neurological signs in four (36%); sensory
impairment in three (27%); vomiting in three patients (27%) and seizures in one (9%).
Only one patient (9%) had no signs or symptoms of neurological involvement and, in this
case, the identification of VZV in CSF was an incidental finding. Eight patients (72%)
presented concomitant mucocutaneous lesions, compatible with VZV eruptions. Median of
CSF glucose was 51 mg/dL (range: 30-114 mg/dL) and median of cellularity was 57 cells/mL
(range 1-950 cells/mL); six patients (54.5%) presented pleocytosis. All patients showed
high CSF protein concentration with a median of 2.1 g/dL (range: 0.65-3.45 g/dL). In all
cases, PCR was positive for VZV and negative for HSV-1, HSV-2, HHV-6, EBV and CMV,
either by MHV or RT-PCR. Main results are summarized in <xref ref-type="table" rid="t02">Table 2</xref>.</p>
      <p>
<table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><title>
<bold>-</bold> Main clinical characteristics </title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>#</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Meningism</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Seizures</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Headache</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Fever</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Concomitantmucocutaneous lesions</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Focalneurological signs</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>PCR-VZV-CSF</bold>
</th><th align="left" rowspan="1" colspan="1">
<bold>Outcome</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Survival</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Survival</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Death</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Survival</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Survival</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Death</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Survival</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Survival</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Survival</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Death</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Present</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">Death</td></tr></tbody></table><table-wrap-foot><fn id="TFN02"><p>PCR-VZV-CSF: cerebrospinal fluid polymerase chain reaction for varicella
zoster virus.</p></fn></table-wrap-foot></table-wrap>
</p>
      <p>All of the patients were treated with intravenous acyclovir at doses of 30/mg/kg/day for
21 days. Overall survival rate was 63% (seven of 11 patients). The four dead patients
had low cellular count in CSF, below the median of this parameter (median: 3 cells/&#xB5;L,
IHQ: 7.5 cells/&#xB5;L), but the clinical presentation did not differ from the entire cohort.
</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Reactivation of VZV infection in the CNS is more common in patients with AIDS in
comparison with other immunodeficient patients and immunocompetent individuals. This
population accounts for 2% of the cases with neurological involvement. GRAY <italic>et
al.</italic> (1994)<xref rid="B08" ref-type="bibr">8</xref> reported VZV reactivation
in CNS in more than 4% of AIDS patients. Meningoencephalitis is more frequent than
myelitis<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>. The pathogenic mechanisms of VZV reactivation
in the CNS include neuronal and glial direct infection and immune mediated lesions
including vasculitis and demyelization<xref rid="B07" ref-type="bibr">7</xref>. </p>
      <p>Clinical manifestations include diffuse meningoencephalitis, focal encephalitis and
meningoencephalomyelitis. VZV myelitis, as the only manifestation of the disease, is
rare and occurs in less than 1/1000 cases<xref rid="B02" ref-type="bibr">2</xref>.</p>
      <p>In the HIV population, VZV reactivation in the CNS is associated with a low CD4+ T cell
count and, in the majority of the patients, mucocutaneous lesions precede CNS
involvement. In addition, some patients present early neurological manifestations of
meningoencephalitis before maculovesicular exanthema appear while others have late
complications such as vasculitis with granulomatous angeitis<xref rid="B09" ref-type="bibr">9</xref>. Nevertheless, detection of VZV in CSF is possible in the absence
of rash. In our series, we could detect mucocutaneous eruptions with foamy virus in
Tzanck cytodiagnosis compatible with VZV in eight of the 11 patients (72%). The most
common clinical picture in our series was the meningeal signs (36%) associated with
fever (63%) and headache (72%).</p>
      <p>Diagnosis of VZV meningoencephalitis includes neurological manifestations, a positive
CSF result for VZV DNA, and the absence of any other identifiable pathogen in CSF. All
of the patients described in this report, excepting for one case, presented these three
clinical and laboratory findings. </p>
      <p>Since its introduction in 1990, the PCR technique has contributed to the diagnosis of
neurological infections caused by herpesvirus. This very sensitive and specific
technique has overwhelmed the serological diagnosis of neuroherpeviruses infections in
CSF<xref rid="B01" ref-type="bibr">1</xref>. Amplification of VZV DNA in CSF by PCR
is the gold standard method in diagnosis of the clinical spectrum of neurological
disorders associated with herpesvirus<xref rid="B02" ref-type="bibr">2</xref>
<sup>,</sup>
<xref rid="B10" ref-type="bibr">10</xref>. When the CSF sample is taken within the first
few days after the onset of neurological symptoms, the rate of PCR positive is higher
than afterwards<xref rid="B01" ref-type="bibr">1</xref>
<sup>,</sup>
<xref rid="B03" ref-type="bibr">3</xref>. The overall sensitivity is approximately 90%
with a specificity of 100%<xref rid="B12" ref-type="bibr">12</xref>. </p>
      <p>Another interesting issue that concerns the viral load evaluation in the analysis of CSF
samples is the future incorporation of the quantitative VZV RT-PCR, which is being
applied more and more<xref rid="B04" ref-type="bibr">4</xref>. </p>
      <p>Information on VZV meningoencephalitis series in HIV-infected patients is still limited.
To date, very few cases of VZV meningoencephalitis in HIV-infected patients have been
published. In a large series of 514 consecutive HIV infected patients with neurological
disorders, VZV DNA was found in CSF samples of 2.5% of the cases (13 patients). Only
four of these 13 patients had the diagnosis of VZV meningoencephalitis or
encephalomyelitis<xref rid="B01" ref-type="bibr">1</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">5</xref>. To the best of our knowledge, this is the
larger series of CNS reactivation of VZV in HIV/AIDS patients.</p>
      <p>In conclusion, reactivation of VZV in CNS is a severe and life-threatening complication
in HIV/AIDS patients. Infectologists should consider the presence of VZV DNA in CSF
concomitantly with other viruses, or simultaneously with the occurrence of HIV
neurological complications, either in the presence or absence of mucocutaneous lesions
of VZV.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by" id="fn02">
        <p>Financial funding: None.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cinque</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vago</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dahl</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Brytting</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Terreni</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Fornara</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Polymerase chain reaction on cerebrospinal fluid for diagnosis of
virus associated opportunistic diseases of the central nervous system in
HIV-infected patients</article-title>
          <source>AIDS</source>
          <year>1996</year>
          <volume>10</volume>
          <fpage>951</fpage>
          <lpage>958</lpage>
          <pub-id pub-id-type="pmid">8853727</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trione</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Villafa&#xF1;e</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Risso</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Yampolsky</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mamanna</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Acute meningoencephalomyelitis due to Varicella-Zoster virus in an
AIDS patient: report of a case and review of the literature</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2011</year>
          <volume>44</volume>
          <fpage>784</fpage>
          <lpage>786</lpage>
          <pub-id pub-id-type="pmid">22231256</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Villafa&#xF1;e</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Trione</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mamanna</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bouzas</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Human herpesvirus 6: report of emerging pathogen in five patients with
HIV/AIDS and review of the literature</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2011</year>
          <volume>44</volume>
          <fpage>522</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="pmid">21860905</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaeta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Verzaro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Latte</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Mancini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nazzari</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis of neurological herpesvirus infections: real time PCR in
cerebral spinal fluid analysis</article-title>
          <source>New Microbiol</source>
          <year>2009</year>
          <volume>32</volume>
          <fpage>333</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="pmid">20128439</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilden</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Beinlich</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Rubisntein</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Stommel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Swenson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rubisntein</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Varicella-zoster virus myelitis: an expanding spectrum</article-title>
          <source>Neurology</source>
          <year>1994</year>
          <volume>44</volume>
          <fpage>1818</fpage>
          <lpage>1823</lpage>
          <pub-id pub-id-type="pmid">7936229</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilden</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Kleinschmidt-DeMasters</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>La Guardia</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Mahalingam</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cohrs</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Neurologic complications of the reactivation of varicella-zoster
virus</article-title>
          <source>N Engl J Med</source>
          <year>2000</year>
          <volume>342</volume>
          <fpage>635</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="pmid">10699164</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glesby</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Chaisson</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Clinical spectrum of herpes zoster in adults infected with human
immunodeficiency virus</article-title>
          <source>Clin Infect Dis</source>
          <year>1995</year>
          <volume>21</volume>
          <fpage>370</fpage>
          <lpage>375</lpage>
          <pub-id pub-id-type="pmid">8562746</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gray</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>B&#xE9;lec</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lescs</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Chr&#xE9;tien</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ciardi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hassine</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Varicella-Zoster virus infection of the central nervous system in the
acquired immune deficiency syndrome</article-title>
          <source>Brain</source>
          <year>1994</year>
          <volume>117</volume>
          <fpage>987</fpage>
          <lpage>999</lpage>
          <pub-id pub-id-type="pmid">7953606</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mart&#xED;n del Pozo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Benito-Le&#xF3;n</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>D&#xED;az-Guzm&#xE1;n</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bermejo</surname>
              <given-names>FP</given-names>
            </name>
          </person-group>
          <article-title>Uncommon neurologic complications related with varicela-zoster
virus</article-title>
          <source>Neurolog&#xED;a</source>
          <year>1998</year>
          <volume>13</volume>
          <fpage>94</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">9578678</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayo</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Booss</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Varicella zoster associated neurologic disease without skin
lesions</article-title>
          <source>Arch Neurol</source>
          <year>1989</year>
          <volume>46</volume>
          <fpage>313</fpage>
          <lpage>315</lpage>
          <pub-id pub-id-type="pmid">2537615</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgello</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Block</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Petito</surname>
              <given-names>CK</given-names>
            </name>
          </person-group>
          <article-title>Varicella-zoster virus leukoencephalitis and cerebral
vasculopathy</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>1988</year>
          <volume>112</volume>
          <fpage>173</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">3337629</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puchhammer-St&#xF6;ckl</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Popow-Kraupp</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Heinz</surname>
              <given-names>FX</given-names>
            </name>
            <name>
              <surname>Mandl</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Kunz</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Detection of varicella-zoster virus DNA by polymerase chain reaction
in cerebrospinal fluid of patients suffering neurological complications associated
with chicken pox or herpes zoster</article-title>
          <source>J Clin Microbiol</source>
          <year>1991</year>
          <volume>29</volume>
          <fpage>1513</fpage>
          <lpage>1516</lpage>
          <pub-id pub-id-type="pmid">1653267</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toledo</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Pellegrino</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Varicella-zoster virus encephalitis in an AIDS patient</article-title>
          <source>Braz J Infect Dis</source>
          <year>2004</year>
          <volume>8</volume>
          <fpage>255</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="pmid">15476058</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
